6533b833fe1ef96bd129bfdd
RESEARCH PRODUCT
RISK OF HEMOLYMPHOPOIETIC NEOPLASM BEFORE AND AFTER THYROID CANCER. A POPULATION‐BASED STUDY IN ITALY, 1998‐2012
Manuel ZorziSalvatore VaccarellaCinzia GasparottiL. GuardaL. Dal MasoSilvia FranceschiSilvia IacovacciSusanna BuscoFabrizio StracciGiovanna TagliabueM. VarvaràWalter MazzuccoStefano FerrettiR. CavalloM FuscoRosario TuminoAntonio RussoStefano RossoAdele CaldarellaYlenia M DinaroGuido MazzoleniUgo FedeliDaniela PirasP. PinnaCarlotta BuzzoniFederica ToffoluttiAntonino MusolinoClaudia CasellaGiuliano CarrozziLucia MangoneFabio FalciniSilvano PifferVeronica MattioliA.c. FanettiD. SerrainoEmanuele Crocettisubject
OncologyCancer Researchmedicine.medical_specialtybusiness.industryHematologyGeneral Medicinemedicine.diseasePopulation based studyOncologyInternal medicinemedicineNeoplasmbusinessThyroid cancer| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-06-01 | Hematological Oncology |